Clinical and genetic factors predicting response to therapy in patients with Crohn’s disease

Aim - To identify clinical and/or genetic predictors of response to several therapies in Crohn’s disease (CD) patients. Methods - We included 242 patients with CD (133 females) aged (mean ± standard deviation) 39 ± 12 years and a disease duration of 12 ± 8 years. The single-nucleotide polymorphisms (SNPs) studied were ABCB1 C3435T and G2677T/A, IL23R G1142A, C2370A, and G9T, CASP9 C93T, Fas G670A and LgC844T, and ATG16L1 A898G. Genotyping was performed with real-time PCR with Taqman probes. Results - Older patients responded better to 5-aminosalicylic acid (5-ASA) and to azathioprine (OR 1.07, p = 0.003 and OR 1.03, p = 0.01, respectively) while younger ones responded better to biologicals (OR 0.95, p = 0.06). Previous surgery negatively influenced response to 5-ASA compounds (OR 0.25, p = 0.05), but favoured response to azathioprine (OR 2.1, p = 0.04). In respect to genetic predictors, we observed that heterozygotes for ATGL16L1 SNP had a significantly higher chance of responding to corticosteroids (OR 2.51, p = 0.04), while homozygotes for Casp9 C93T SNP had a lower chance of responding both to corticosteroids and to azathioprine (OR 0.23, p = 0.03 and OR 0.08, p = 0.02,). TT carriers of ABCB1 C3435T SNP had a higher chance of responding to azathioprine (OR 2.38, p = 0.01), while carriers of ABCB1 G2677T/A SNP, as well as responding better to azathioprine (OR 1.89, p = 0.07), had a lower chance of responding to biologicals (OR 0.31, p = 0.07), which became significant after adjusting for gender (OR 0.75, p = 0.005). Conclusions - In the present study, we were able to identify a number of clinical and genetic predictors of response to several therapies which may become of potential utility in clinical practice. These are preliminary results that need to be replicated in future pharmacogenomic studies.

Relatório de estágio de natureza profissional em PET/CT: Clinical Imaging Sciences Centre, Sussex

Mestrado em Medicina Nuclear - Ramo de especialização: Tomografia por Emissão de Positrões

Health related quality of life in patients with refractory chronic heart failure undergoing cardiac resynchronization: type of therapeutic response

The benefits of cardiac resynchronization therapy (CRT) in the health-related quality of life (HRQL) are largely demonstrated in selected patients with severe congestive heart failure (CHF). However, the differences between responders and non-responders, with regard to the effect of CRT in the various dimensions that constitute HRQL are still a matter of discussion. Objective: To evaluate the impact of CRT on the HRQL of patients with CHF refractory to optimal pharmacological therapy, within 6 months after CRT. Methods: 43 patients, submitted to successful implantation of CRT, were evaluated in hospital just before intervention and in the outpatient clinic within 6 months after CRT. HRQL was analyzed based on the Kansas City Cardiomyopathy Questionnaire (KCCQ). Patients were classified as super-responders (ejection fraction of left ventricle - LVEF - ≥45% post-CRT), n=15, responders (sustained improvement in functional class and LVEF increased by 15%), n=19, and non-responders (no clinical or LVEF improvement), n=9. Results: In the group of super-responders, CRT was associated with an improvement in HRQL for the various fields and sums assessed (ρ<0.05); in responders, CRT has been associated with an improvement of HRQL in the various fields and sums, except in the self-efficacy dimension (ρ<0.05); in non-responders, CRT was not associated with improvement of HRQL. Conclusion: In a population with severe CHF undergoing CRT, the patients with clinical and echocardiographic positive response, obtained a favorable impact in all dimensions of HRQL, while the group without response to CRT showed no improvement. These data reinforces the importance of HRQL as a multidimensional tool for assessment of benefits in clinical practice.

Digital radiography detectors - A technical overview: Part 1

During the last two decades screen-film (SF) systems have been replaced by digital X-ray systems. The advent of digital technologies brought a number of digital solutions based on different detector and readout technologies. Improvements in technology allowed the development of new digital technologies for projection radiography such as computed radiography (CR) and digital radiography (DR). The large number of scientific papers concerning digital X-ray systems that have been published over the last 25 years indicates the relevance of these technologies in healthcare. There are important differences among different detector technologies that may affect system performance and image quality for diagnostic purposes. Radiographers are expected to have an effective understanding of digital X-ray technologies and a high level of knowledge and awareness concerning the capabilities of these systems. Patient safety and reliable diagnostic information are intrinsically linked to these factors. In this review article - which is the first of two parts - a global overview of the digital radiography systems (both CR and DR) currently available for clinical practice is provided.

Digital radiography detectors - A technical overview: Part 2

Digital X-ray detector technologies provide several advantages when compared with screen-film (SF) systems: better diagnostic quality of the radiographic image, increased dose efficiency, better dynamic range and possible reduction of radiation exposure to the patient. The transition from traditional SF systems to digital technology-based systems highlights the importance of the discussion around technical factors such as image acquisition, themanagement of patient dose and diagnostic image quality. Radiographers should be aware of these aspects concerning their clinical practice regarding the advantages and limitations of digital detectors. Newdigital technologies require an up-to-date of scientific knowledge concerning their use in projection radiography. This is the second of a two-part review article focused on a technical overview of digital radiography detectors. This article provides a discussion about the issues related to the image acquisition requirements and advantages of digital technologies, the management of patient dose and the diagnostic image quality.

Evaluation of exposure index (IgM) in orthopaedic radiography

The exposure index (lgM) obtained from a radiographic image may be a useful feedback indicator to the radiographer about the appropriate exposure level in routine clinical practice. This study aims to evaluate lgM in orthopaedic radiography performed in the standard clinical environment. We analysed the lgM of 267 exposures performed with an AGFA CR system. The mean value of lgM in our sample is 2.14. A significant difference (P=0.000<0.05) from 1.96 lgM reference is shown. Data show that 72% of exposures are above the 1.96 lgM and 42% are above the limit of 2.26. Median values of lgM are above 1.96 and below 2.26 for Speed class (SC) 200 (2.16) and SC400 (2.13). The interquartile range is lower in SC400 than in SC200. Data seem to indicate that lgM values are above the manufacturer’s reference of 1.96. Departmental exposure charts should be optimised to reduce the dose given to patients.

Monitorização da insuficiência cardíaca por parâmetros fisiológicos em portadores de cardioversor-desfibrilhador implantável e/ou sistema de ressincronização cardíaca: HF-PREDICT

Mestrado em Tecnologia de Diagnóstico e Intervenção Cardiovascular. Área de especialização: Intervenção Cardiovascular.

Evaluation of the respiratory motion effect in small animal PET images with GATE Monte Carlo simulations

The rapid growth in genetics and molecular biology combined with the development of techniques for genetically engineering small animals has led to increased interest in in vivo small animal imaging. Small animal imaging has been applied frequently to the imaging of small animals (mice and rats), which are ubiquitous in modeling human diseases and testing treatments. The use of PET in small animals allows the use of subjects as their own control, reducing the interanimal variability. This allows performing longitudinal studies on the same animal and improves the accuracy of biological models. However, small animal PET still suffers from several limitations. The amounts of radiotracers needed, limited scanner sensitivity, image resolution and image quantification issues, all could clearly benefit from additional research. Because nuclear medicine imaging deals with radioactive decay, the emission of radiation energy through photons and particles alongside with the detection of these quanta and particles in different materials make Monte Carlo method an important simulation tool in both nuclear medicine research and clinical practice. In order to optimize the quantitative use of PET in clinical practice, data- and image-processing methods are also a field of intense interest and development. The evaluation of such methods often relies on the use of simulated data and images since these offer control of the ground truth. Monte Carlo simulations are widely used for PET simulation since they take into account all the random processes involved in PET imaging, from the emission of the positron to the detection of the photons by the detectors. Simulation techniques have become an importance and indispensable complement to a wide range of problems that could not be addressed by experimental or analytical approaches.

Quantificação da difusão na ressonância magnética da mama: ADC e Kurtosis

Mestrado em Radiações Aplicadas às Tecnologias da Saúde. Área de especialização: Ressonância Magnética

Digital radiography detectors: a technical overview

Developments in digital detector technologies have been taking place and new digital technologies are available for clinical practice. This chapter is intended to give a technical state-of-the-art overview about computed radiography (CR) and digital radiography (DR) detectors. CR systems use storage-phosphor image plates with a separate image readout process and DR technology converts X-rays into electrical charges by means of a readout process using TFT arrays. Digital detectors offer several advantages when compared to analogue detectors. The knowledge about digital detector technology for use in plain radiograph examinations is thus a fundamental topic to be acquired by radiology professionals and students. In this chapter an overview of digital radiography systems (both CR and DR) currently available for clinical practice is provided.

Technical considerations concerning digital technologies

This chapter addresses technical issues concerning digital technologies. Radiological equipment and technique are briefly introduced together with a discussion about requirements and advantages of digital technologies. Digital technologies offer several advantages when compared to conventional analogical systems, or screen–film (SF) systems. While in clinical practice the practitioners should be aware of technical factors such as image acquisition, management of patient dose, and diagnostic image quality. Thus, digital technologies require an up-to-date scientific knowledge concerning their use in projection radiography. In this chapter, technical considerations concerning digital technologies are provided.

Practical insights into digital radiology

Digital radiography detectors—based on different technological solutions—are currently available for clinical applications and widespread in clinical practice. Computed radiography (CR) and digital radiology systems have been available for clinical applications and the trend over the last few years has become digital. Radiology departments have been changing from traditional screen–film technology to digital technology. This chapter is intended to give the reader a practical understanding about the key aspects concerning digital systems, related to the performance of different technologies, image quality, and dose and patient safety/protection. The discussion around an optimization framework for digital systems is provided.

Validação do dispositivo automático de medição da pressão arterial, OMRON® M6 Comfort, segundo o Protocolo Internacional da Sociedade Europeia de Hipertensão (2010)

Introdução – A medição da pressão arterial (PA), utilizando dispositivos automáticos, é frequentemente realizada na prática clínica e na automedição, permitindo adquirir informação fiável para o diagnóstico, controlo e tratamento da hipertensão arterial. Porém, muitos dos dispositivos automáticos disponíveis no mercado não estão validados segundo protocolos existentes para o efeito. O objetivo do estudo foi confirmar a validação do dispositivo de medição automática da PA, OMRON® M6 Comfort, segundo o Protocolo Internacional da European Society of Hypertension (ESH), de 2010, para a validação de dispositivos de medição automática da PA em adultos. Metodologia – Foram estudados 33 indivíduos, aos quais foram realizadas 9 medições sequenciais da PA, no braço esquerdo, com um esfignomanómetro aneróide alternando com o dispositivo automático. Seguidamente avaliaram-se as diferenças entre os valores obtidos pelos dispositivos para a pressão arterial sistólica (PAS) e diastólica (PAD), classificando-as em três níveis (≤ 5, ≤ 10 ou ≤ 15 mmHg). O número das diferenças em cada nível foi comparado ao requerido pelo Protocolo (fase 1.1). Para cada sujeito foi ainda determinado o número de diferenças com valores ≤ 5 mmHg. Pelo menos 24 dos 33 indivíduos devem ter 2 ou 3 diferenças com valores ≤ 5 mmHg e no máximo 3 dos 33 indivíduos podem apresentar as 3 diferenças com valores > 5 mmHg (fase 1.2). Resultados – O dispositivo OMRON® M6 Comfort foi aprovado nas fases 1.1 e 1.2 para a PAS e PAD. A média das diferenças entre as medições da PA, determinada pelos dispositivos automático e manual, foi de -0,82 ± 5,62 mmHg para a PAS e 2,14 ± 5,15 mmHg para a PAD. Considerações Finais – O dispositivo OMRON® M6 Comfort é válido para a medição da PA em adultos, de acordo com o Protocolo Internacional da ESH, de 2010. - ABSTRACT - Introduction – The measurement of blood pressure (BP) using automatic devices is often performed in clinical practice and self-measurement allowing the acquisition of reliable information for the diagnosis, monitoring and treatment of hypertension. However not all of the automated devices available in the market are validated in accordance with the existing protocols for this purpose. The purpose of this study was to confirm the validation of the automatic measuring device of the BP, OMRON® M6 Comfort, according to the “European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults”. Methodology – The study involved 33 subjects, in each one of them, 9 sequential measurements of BP were performed, in the left arm, with the aneroid sphygmomanometer alternating with the automatic device. Afterwards, the differences on the values obtained by the different devices were evaluated, for systolic blood pressure (SBP) and diastolic (DBP), and these differences were then classified into three levels (≤ 5, ≤ 10 or ≤ 15 mmHg). The number of differences at each level was compared to the number required by the protocol (phase 1.1). For each subject the number of differences with values ≤ 5 mmHg was also determined. At least 24 of the 33 subjects should have 2 or 3 differences with values ≤ 5 mmHg and a maximum of 3 of the 33 subjects may have all differences with values > 5 mmHg (phase 1.2). Results – The device OMRON M6 Comfort ® was approved in phases 1.1 and 1.2 for SBP and DBP. The average difference between measurements of BP, as determined by automatic and manual devices, was -0.82 ± 5.62 mmHg for SBP and 2.14 ± 5.15 mmHg for DBP. Conclusion – The device OMRON M6 Comfort® is valid for measuring BP in adults, according to the ESH International Protocol of 2010.

Estudo dosimétrico comparativo do Acuros® XB: algoritmo avançado de cálculo de dose com o AAA – Anisotropic Analytical Alghorithm, em tratamentos de radioterapia externa com a técnica de RapidArc™

Mestrado em Radioterapia.

Neonatal anthropometry: a tool to evaluate the nutritional status and predict early and late risks

Neonatal anthropometry is an inexpensive, noninvasive and convenient tool for bedside evaluation, especially in sick and fragile neonates. Anthropometry can be used in neonates as a tool for several purposes: diagnosis of foetal malnutrition and prediction of early postnatal complications; postnatal assessment of growth, body composition and nutritional status; prediction of long-term complications including metabolic syndrome; assessment of dysmorphology; and estimation of body surface. However, in this age group anthropometry has been notorious for its inaccuracy and the main concern is to make validated indices available. Direct measurements, such as body weight, length and body circumferences are the most commonly used measurements for nutritional assessment in clinical practice and in field studies. Body weight is the most reliable anthropometric measurement and therefore is often used alone in the assessment of the nutritional status, despite not reflecting body composition. Derived indices from direct measurements have been proposed to improve the accuracy of anthropometry. Equations based on body weight and length, mid-arm circumference/head circumference ratio, and upper-arm cross-sectional areas are among the most used derived indices to assess nutritional status and body proportionality, even though these indices require further validation for the estimation of body composition in neonates.